California and Florida have the most top-ranked hospitals for pacemaker or defibrillator placement in the U. S. , according to the WebMD Choice Awards.

On Wednesday, Boston Scientific Corporation (NYSE:BSX) released the results of the primary endpoint of the ACURATE IDE trial of ACURATE neo2 Aortic Valve System for patients with severe ...

Boston Scientific continues to work closely with the U.S. Food and Drug Administration on the regulatory strategy for approval of the ACURATE valve platform in the U.S. The ACURATE neo2 Aortic ...

is spending $10 million to launch a new institute in Greater Boston that would focus on the interplay between scientific issues and social ones. He’s hopeful that the work can be helpful to ...

Epicardial pacemaker and defibrillator systems are commonly used in pediatrics, but have a high rate of lead failure. Wound- and lead-related problems and infections are not uncommonly encountered ...

Dual-chamber pacemaker: Has two leads connected to both the right atrium and right ventricle, helping to coordinate the timing between the top and bottom chambers. Implantable ...

Boston Scientific Corporation (NYSE ... which received FDA approval in the quarter and our EMPOWUR leadless pacemaker, which ...

AI-infused search engines from Google, Microsoft, and Perplexity have been surfacing deeply racist and widely debunked research promoting race science and the idea that white people are ...

The Pawtucket, Rhode Island-based toy company’s workforce is being tightened amid its ploy to uproot its headquarters to Boston. The international company has been a fixture in the Ocean State ...

Strong sales of a medical device to treat atrial fibrillation helped lift Boston Scientific’s top line last quarter, but an unexpected pause in an important clinical trial to expand the use of ...

Marlborough-based Boston Scientific increased its estimated net sales growth for 2024. Meanwhile, Thermo Fisher slightly raised its full-year adjusted earnings per share guidance. Boston ...